Wolfgang Bernhard Liedtke dating history

Details

Wolfgang Bernhard Liedtke is a German-American neurologist and biotech-pharma executive currently serving as Senior Vice President and Global Head of Neurology at Anavex Life Sciences (New York NY). In this role, he leads late-stage clinical development in Alzheimer's and Parkinson's disease, the open-label extension of Anavex' registrational Alzheimer's trial AD-004 — conducted in synchrony with the European Medicines Agency — as well as early-stage clinical development in schizophrenia (trial SZ-001). He was previously a corporate executive at Regeneron Pharmaceuticals in Tarrytown, New York, where he served as Chair of Neurology, Psychiatry, Pain Medicine, and Sensory Systems on the Scientific Council in Global Development (Genetic Medicines) from 2021 to 2024.